日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients

PD-1阻断剂不会增强癌症患者接受同种异体树突状细胞疫苗接种后的同种免疫反应。

Planel, Severine; Vayssière, Guillaume; Maggipinto, Gianni; Leplus, Estelle; Laulagnier, Karine; Renard, Florence; Myster, Francoise; Gerard, Marie; Demedts, Ingel; Cuppens, Kristof; Pons-Tostivint, Elvire; Wauters, Els; Borm, Frank J; Sibille, Anne; Colinet, Benoît; Pérol, Maurice; Theelen, Willemijn S M E; Biesma, Bonne; Van De Kerkhove, Charlotte; Buchmeier, Eva; Althoff, Friederike C; Derijcke, Sofie; Moro-Sibilot, Denis; Cantero, Frédérique; Chaperot, Laurence; Saas, Philippe; Skrzypski, Marcin; Vansteenkiste, Johan; Plumas, Joël

Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment

叶酸预防和剂量调整可确保肾功能不全患者安全使用培美曲塞治疗。

de Rouw, Nikki; Otten, Leila-Sophie; Kicken, Mart P; Piet, Berber; Biesma, Bonne; van Veggel, Bianca; Steendam, Christi M J; van den Borne, Ben; Hendriks, Lizza E L; Croes, Sander; Dingemans, Anne-Marie C; Dumoulin, Daphne W; Mathijssen, Ron H J; Burgers, Jacobus A; Huitema, Alwin D R; Derijks, Hieronymus J; Deenen, Maarten J; van den Heuvel, Michel M; Ter Heine, Rob

Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial

基于肾功能的培美曲塞给药方案与标准剂量方案的比较:一项随机对照试验

de Rouw, Nikki; Boosman, René J; Burgers, Jacobus A; Huitema, Alwin D R; Dingemans, Anne-Marie C; Derijks, Hieronymus J; Burger, David M; Piet, Berber; Hendriks, Lizza E L; Biesma, Bonne; Pruis, Melinda A; Dumoulin, Daphne W; Croes, Sander; Mathijssen, Ron H J; van den Heuvel, Michel M; Ter Heine, Rob

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response.

对间皮瘤患者的免疫监测发现了吉西他滨与临床反应相关的新型免疫调节功能

Dammeijer Floris, De Gooijer Cornedine J, van Gulijk Mandy, Lukkes Melanie, Klaase Larissa, Lievense Lysanne A, Waasdorp Cynthia, Jebbink Merel, Bootsma Gerben P, Stigt Jos A, Biesma Bonne, Kaijen-Lambers Margaretha E H, Mankor Joanne, Vroman Heleen, Cornelissen Robin, Baas Paul, Van der Noort Vincent, Burgers Jacobus A, Aerts Joachim G

Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity

在荷兰实施新型分子生物标志物检测非小细胞肺癌:如何应对日益复杂的挑战

van den Broek, Daan; Hiltermann, T Jeroen N; Biesma, Bonne; Dinjens, Winand N M; 't Hart, Nils A; Hinrichs, John W J; Leers, Mathie P G; Monkhorst, Kim; van Oosterhout, Matthijs; Scharnhorst, Volkher; Schuuring, Ed; Speel, Ernst-Jan M; van den Heuvel, Michel M; van Schaik, Ron H N; von der Thüsen, Jan; Willems, Stefan M; de Visser, Leonie; Ligtenberg, Marjolijn J L

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

凡德他尼联合多西他赛对比单用多西他赛作为晚期非小细胞肺癌患者二线治疗方案(ZODIAC):一项双盲、随机、3期临床试验

Herbst, Roy S; Sun, Yan; Eberhardt, Wilfried E E; Germonpré, Paul; Saijo, Nagahiro; Zhou, Caicun; Wang, Jie; Li, Longyun; Kabbinavar, Fairooz; Ichinose, Yukito; Qin, Shukui; Zhang, Li; Biesma, Bonne; Heymach, John V; Langmuir, Peter; Kennedy, Sarah J; Tada, Hiroomi; Johnson, Bruce E

Randomized phase II study of gefitinib compared with placebo in chemotherapy-naive patients with advanced non-small-cell lung cancer and poor performance status

一项随机II期研究,比较吉非替尼与安慰剂在未接受化疗的晚期非小细胞肺癌且体能状态较差的患者中的疗效。

Goss, Glenwood; Ferry, David; Wierzbicki, Rafal; Laurie, Scott A; Thompson, Joyce; Biesma, Bonne; Hirsch, Fred R; Varella-Garcia, Marileila; Duffield, Emma; Ataman, Ozlem U; Zarenda, Marc; Armour, Alison A